BioSpace News Archive

Inguinal hernia is a disorder in which part of the small intestine or intra-abdominal fat, bulges in the lower intestinal muscles through a delicate area.

The global plasma fractionation market is all set to gather handsome amount in revenues during the forecast period of 2018 to 2026, states a recently published report by Transparency Market Research (TMR).

The global lymphoma treatment market is expected to grow at a favorable rate from 2021 to 2031 (forecast period).

Increase in demand for detection of virus removal/inactivation in products during their early stages of development, rise in R&D expenditure, growing preference for outsourcing of viral clearance service to contract research organizations, rise in consumer awareness about safety associated with the use of health care and vaccines, and increase in concern of viral effects of blood-derived products are some factors boosting the demand for viral clearance service.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the first implantation of its prodisc® C Vivo Cervical Total Disc Replacement (TDR) product.

Demand for renal denervation procedures is anticipated to be aided by various authorities and government organizations increasing funding for R&D initiatives for renovascular hypertension treatment.

Visus Therapeutics, Inc. announced that Ben Bergo, co-founder and chief executive officer, will present at the Baird 2022 Global Healthcare Conference on September 13th, 2022, at the InterContinental New York Barclay hotel.

TearLab® Corporation, the global leader in ophthalmic point-of-care diagnostics, announced that it will be expanding its position in corneal health under the new name Trukera™ Medical.

Biosion, Inc. announced the appointment of Rakesh Dixit, Ph.D., DABT to its Advisory Board to advance Antibody Drug-Conjugates for the treatment of solid tumor cancers in Biosion’s pipeline.

INmune Bio (NASDAQ: INMB), announced today that RJ Tesi, M.D., Chief Executive Officer will present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12 - 14, 2022, and the Baird Global Healthcare Conference being held on September 13 – 14, 2022.